Twareat Medical Center (TMC) posted SAR 5.5 million in net profit for the first half of 2025, down 66% from SAR 16.1 million in the year-ago period.
Item | H1 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 92.23 | 90.72 | (1.6 %) |
Gross Income | 35.20 | 26.44 | (24.9 %) |
Operating Income | 16.74 | 7.01 | (58.1 %) |
Net Income | 16.13 | 5.53 | (65.7 %) |
Average Shares | 40.00 | 40.00 | - |
Earnings Per Share before unusual items (Riyal) | 0.40 | 0.14 | (65.7 %) |
EPS (Riyal) | 0.40 | 0.14 | (65.7 %) |
Item | H2 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 99.58 | 90.72 | (8.9 %) |
Gross Income | 25.45 | 26.44 | 3.9 % |
Operating Income | 9.54 | 7.01 | (26.5 %) |
Net Income | 7.39 | 5.53 | (25.2 %) |
Average Shares | 40.00 | 40.00 | - |
Earnings Per Share before unusual items (Riyal) | 0.18 | 0.14 | (25.2 %) |
EPS (Riyal) | 0.18 | 0.14 | (25.2 %) |
The first-half profit decline was attributed to lower revenues, the expiration of certain medical service contracts, as well as higher financing costs and Zakat provisions.
Sequentially, net profit fell by 25.2% from SAR 7.39 million in H2 2024.
Shareholders’ equity, no minority interest, amounted to SAR 62.76 million by the end of H1 2025, compared to SAR 60.69 million in H1 2024.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: